Unplanned secondary analysis of the A-PLUS RCT (29,278 women in labour in 7 low- and middle-income countries): single oral azithromycin 2 g did not significantly reduce postpartum haemorrhage (1.4% vs 1.6% placebo; RR 0.88, 95% CI 0.73–1.07) or transfusion (0.5% vs 0.5%).
Secondary analysisn = 29,278
Sidze et al. Intrapartum oral azithromycin for maternal infection prophylaxis and the risk of postpartum hemorrhage: A secondary analysis of the A-PLUS trial